Biotech Rips On Dual Announcement

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, July 1, 2025

A European biotech company is stealing the show so far during Tuesday’s session after the company announced positive topline results from the eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial evaluating the efficacy and safety of a single dose of BPL-003 in patients with treatment-resistant depression (TRD).

On top of these key findings, the company announced a $50 million private placement. Traders couldn’t get their hands on shares fast enough as they pushed ATAI Life Sciences N.V. (Nasdaq:ATAI) up to $2.895/share (+32.19%) at the early session high. This move is a strong continuation of the success this stock has had since April.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

This AI Microcap Just Put a Profit Number on Its Strategy

Gravity and Proof: Why Concentrate Economics Are the Next Test for Brazil Gold

High-Grade Success Sparks Rally for Arizona Gold Explorer

Most Popular

{{ index + 1 }}

AllPennyStocks.com Favorites

This Biotech Duo Has More In Common Than Their Industry

Enable Free Access to Unlock Up to Two Articles Per Month.

This Oregon-Based Micro Cap Has Room To Run

Enable Free Access to Unlock Up to Two Articles Per Month.

Company Spotlight: ESGold Corp. (CSE:ESAU)

Nasdaq listed, Lantern Pharma Inc. looks ready to rally as the stock exhibited a Golden Cross (50 DMA / 200 DMA). With a closing price of $3.60, we continue to monitor this technical signal for future potential upward movement.

Canadian Securities Exchange listed, Vencanna Ventures Inc. was a standout in Friday's trade. The stock popped 100.00%, closing out the day at $0.01.

OTC Markets traded, Stargaze Entertainment Group Inc took off in Friday's trading session. Shares climbed an impressive 66.37%, ending the day at $0.02.

The Math Here Is Hard to Ignore

Enable Free Access to Unlock Up to Two Articles Per Month.

This Biotech Has An Extremely Attractive Risk:Reward Setup

Enable Free Access to Unlock Up to Two Articles Per Month.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2026 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.